Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors - Archive ouverte HAL Access content directly
Journal Articles Annals of Surgical Oncology Year : 2016

Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors

, , (1) , , , (2) , , , , , , , ,
1
2
T. Charrier
  • Function : Author
G. Passot
  • Function : Author
C. Maurice
  • Function : Author
S. Gocevska
  • Function : Author
C. Eveno
  • Function : Author
M. Pocard
D. Goere
  • Function : Author
D. Elias
  • Function : Author
P. Ortega-Deballon
  • Function : Author
D. Vaudoyer
  • Function : Author
E. Cotte
  • Function : Author
O. Glehen
  • Function : Author
Not file

Dates and versions

hal-02016407 , version 1 (12-02-2019)

Identifiers

Cite

T. Charrier, G. Passot, Julien Péron, C. Maurice, S. Gocevska, et al.. Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors. Annals of Surgical Oncology, 2016, 23, pp.2315-22. ⟨10.1245/s10434-016-5143-1⟩. ⟨hal-02016407⟩
21 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More